What is Zacks Research’s Forecast for PAHC Q2 Earnings?

Phibro Animal Health Co. (NASDAQ:PAHC) – Research analysts at Zacks Research increased their Q2 2025 earnings estimates for Phibro Animal Health in a research note issued on Wednesday, January 15th. Zacks Research analyst R. Department now forecasts that the company will earn $0.36 per share for the quarter, up from their previous forecast of $0.35. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.62 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q4 2025 earnings at $0.43 EPS, FY2025 earnings at $1.49 EPS, Q2 2026 earnings at $0.50 EPS, Q4 2026 earnings at $0.51 EPS, FY2026 earnings at $1.67 EPS and Q2 2027 earnings at $0.54 EPS.

Other research analysts have also issued reports about the stock. Barclays lifted their target price on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a report on Tuesday, November 12th. Morgan Stanley boosted their target price on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Finally, StockNews.com lowered shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Sunday, January 12th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $20.50.

Phibro Animal Health Stock Performance

Shares of PAHC opened at $20.82 on Friday. The company has a market capitalization of $843.21 million, a price-to-earnings ratio of 48.42, a PEG ratio of 0.52 and a beta of 0.53. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23. Phibro Animal Health has a 1 year low of $10.03 and a 1 year high of $25.98. The company’s 50 day simple moving average is $22.50 and its 200 day simple moving average is $21.20.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets increased its holdings in shares of Phibro Animal Health by 3.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock valued at $548,000 after acquiring an additional 729 shares during the last quarter. SG Americas Securities LLC boosted its holdings in Phibro Animal Health by 7.4% in the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock worth $276,000 after purchasing an additional 906 shares during the period. China Universal Asset Management Co. Ltd. increased its stake in Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after purchasing an additional 1,522 shares during the last quarter. Public Sector Pension Investment Board raised its holdings in shares of Phibro Animal Health by 6.1% during the second quarter. Public Sector Pension Investment Board now owns 44,796 shares of the company’s stock worth $751,000 after purchasing an additional 2,583 shares during the period. Finally, Segall Bryant & Hamill LLC lifted its position in shares of Phibro Animal Health by 1.7% in the 3rd quarter. Segall Bryant & Hamill LLC now owns 174,569 shares of the company’s stock worth $3,931,000 after buying an additional 2,971 shares during the last quarter. 99.34% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.31%. The ex-dividend date of this dividend was Wednesday, November 27th. Phibro Animal Health’s payout ratio is 111.63%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.